GleamWall
中文EN

NUWE Nuwellis, Inc.

Electromedical & Electrotherapeutic Apparatus · Nasdaq · SEC CIK 1506492 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY10.3%
TTM net income YoY16.9%
TTM EPS YoY197.4%
Revenue 3-yr CAGR1.4%
Net income 3-yr CAGR—

Margins

Gross margin70.8%
Operating margin-135.8%
Net margin-152.8%
FCF margin-136.6%
EBITDA margin-134.2%

Returns

ROE-200.1%
ROA-128.4%
ROIC (approx.)-815.9%
Asset turnover0.84x

Leverage & solvency

Liabilities / assets26.7%
Debt / equity0.00x
Current ratio3.99x
Interest coverage—

Cash quality & payout

Operating cash flow / net income0.89x
Accruals ratio-13.6%
Payout ratio—
Capex / revenue0.1%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item 2026Q32026-09-302026Q22026-06-302026Q12026-03-312025Q4*2025-12-312025Q32025-09-302025Q22025-06-302025Q12025-03-312024Q4*2024-12-31
Income statement
Revenue$2.21M$1.97M$2.40M$2.42M$2.22M$1.73M$1.90M$2.32M
Cost of revenue$674,000$471,000$719,000$770,000$772,000$767,000$837,000$967,000
Gross profit$1.54M$1.50M$1.68M$1.65M$1.45M$958,000$1.07M$1.35M
R&D expense$584,000$942,000$1.73M$884,000$603,000$675,000$550,000$831,000
SG&A expense$3.01M$3.73M$4.52M$3.21M$3.54M$3.19M$3.58M$2.91M
Operating income-$2.05M-$3.17M-$4.57M-$2.44M-$2.70M-$2.91M-$3.06M-$2.39M
Pretax income-$1.97M-$4.83M-$4.54M-$2.42M$468,000-$12.55M-$3.01M-$1.47M
Income tax$0$0$0$0$0$4,000$1,000$1,000
Net income-$1.97M-$4.83M-$4.54M-$2.42M$468,000-$12.55M-$3.01M-$1.47M
EBITDA-$2.02M-$3.13M-$4.53M-$2.41M-$2.65M-$2.86M-$2.99M-$2.30M
EPS (basic)-5.81-26.64-2.19—177.16-2,134.19-28.93—
EPS (diluted)-5.81-26.64-2.19—177.16-2,134.19-28.93—
Weighted avg. shares (diluted)338,384181,2432.07M—2,6465,881104,142—
Balance sheet
Cash & equivalents$8.29M$3.92M$2.08M$1.08M$3.09M$4.45M$2.56M$5.09M
Receivables$1.39M$1.54M$1.56M$1.49M$1.14M$1.19M$1.54M$1.73M
Inventory$1.77M$1.74M$1.78M$1.91M$2.19M$2.03M$1.75M$1.72M
Current assets$11.93M$7.90M$5.83M$5.19M$7.20M$8.42M$6.12M$8.86M
PP&E, net$303,000$347,000$365,000$368,000$414,000$359,000$405,000$478,000
Intangibles$93,000$102,000$112,000$0————
Total assets$13.45M$9.13M$6.96M$6.12M$7.98M$9.20M$7.01M$9.86M
Current liabilities$2.99M$4.01M$3.73M$3.03M$3.52M$3.89M$2.75M$2.56M
Total liabilities$3.59M$11.17M$4.29M$3.49M$4.07M$18.16M$3.42M$3.33M
Shareholders' equity$9.85M-$2.06M$2.66M$2.62M$3.91M-$8.96M$3.58M$6.53M
Shares outstanding540,912574,4552.64M5,3421.36M527,1584.37M104,142
Cash flow statement
Operating cash flow-$2.98M-$3.17M-$3.11M-$3.03M-$3.15M-$2.10M-$2.54M-$1.50M
Capital expenditure-$22,000$9,000$30,000-$12,000$98,000$4,000$0$23,000
Free cash flow-$2.96M-$3.18M-$3.14M-$3.02M-$3.25M-$2.10M-$2.54M-$1.53M
Investing cash flow$22,000-$9,000-$284,000$12,000-$98,000-$4,000$0-$23,000
Financing cash flow$7.33M$5.02M$4.39M$1.05M$1.89M$4.00M$0$4.72M
Depreciation & amortization$32,000$37,000$38,000$34,000$43,000$50,000$73,000$83,000
Stock-based compensation$8,000$22,000$25,000$24,000$18,000$17,000$67,000$104,000

Free plan shows the latest 8 periods; Pro shows all 63 🔒

· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.